Cargando…

Effects of 1‐Methyl‐3‐propyl‐7‐butylxanthine (MPBX) on Idarubicin‐induced Antitumor Activity and Bone Marrow Suppression

The effects of 1‐methyl‐3‐propyl‐7‐butylxanthine (MPBX), a xanthine derivative, on idarubicin (IDA)‐induced antitumor activity against P388 leukemia cells (P388) and bone marrow suppression were examined. In P388 tumor‐bearing mice, the combination of MPBX with IDA increased the antitumor activity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadzuka, Yasuyuki, Egawa, Youichi, Sugiyama, Tomomi, Sawanishi, Hiroyuki, Miyamoto, Ken‐ichi, Sonobe, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2000
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926398/ https://www.ncbi.nlm.nih.gov/pubmed/10874219 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00995.x

Ejemplares similares

1‐Methyl‐3‐propyl‐7‐butylxanthine, a Novel Biochemical Modulator, Enhances Therapeutic Efficacy of Adriamycin
por: Sadzuka, Yasuyuki, et al.
Publicado: (1998)

Membrane Transport and Antitumor Activity of Pirarubicin, and Comparison with Those of Doxorubicin
por: Sugiyama, Tomomi, et al.
Publicado: (1999)

The field monitoring experiment of the high-level key stratum movement in coal mining based on collaborative DOFS and MPBX
por: Wang, Xiaozhen, et al.
Publicado: (2022)

Caffeine Modulates the Antitumor Activity and Toxic Side Effects of Adriamycin
por: Sadzuka, Yasuyuki, et al.
Publicado: (1993)

Confocal microscopy of idarubicin localisation.
por: Manfait, M., et al.
Publicado: (1997)

Effects of Methylxanthine Derivatives on Adriamycin Concentration and Antitumor Activity
por: Sadzuka, Yasuyuki, et al.
Publicado: (1995)

Confocal microscopy of idarubicin localisation - reply
por: Duffy, P, et al.
Publicado: (1997)

The Basic Study of Liposome in Temperature-Sensitive Gel at Body Temperature for Treatment of Peritoneal Dissemination
por: Sugiyama, Ikumi, et al.
Publicado: (2022)

Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
por: Komiyama, Tomoyoshi, et al.
Publicado: (2016)

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma
por: Chehimi, Mohamad, et al.
Publicado: (2016)

In Vitro Antitumor and Anti-Inflammatory Activities of Allium-Derived Compounds Propyl Propane Thiosulfonate (PTSO) and Propyl Propane Thiosulfinate (PTS)
por: Guillamón, Enrique, et al.
Publicado: (2023)

The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts
por: Dragojew, Sylwia, et al.
Publicado: (2008)

Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
por: Taşkın, Abdullah, et al.
Publicado: (2019)

Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles
por: Barbey, Carole, et al.
Publicado: (2021)

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2020)

Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020)

Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
por: Sherif, Hemat Afifi, et al.
Publicado: (2021)

Correction to “Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles”
por: Barbey, Carole, et al.
Publicado: (2022)

Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA
por: Komiyama, Tomoyoshi, et al.
Publicado: (2018)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
por: Guiu, Boris, et al.
Publicado: (2019)

Effect of CPT‐11 on Lipid Peroxide Level in Mouse Tissues
por: Sadzuka, Yasuyuki, et al.
Publicado: (1997)

Idarubicin Plus Behenoyl Cytarabine and 6-thioguanine Compares Favorably with Idarubicin Plus Cytarabine-based Regimen for Children with Previously Untreated Acute Myeloid Leukemia: 10-Year Retrospective, Multicenter Study in Korea
por: Lee, Dae Hyoung, et al.
Publicado: (2010)

Confocal microscopy of idarubicin localisation in sensitive and multidrug-resistant bladder cancer cell lines.
por: Duffy, P. M., et al.
Publicado: (1996)

Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
por: Fan, Ni, et al.
Publicado: (2017)

Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin
por: Kaya, S. Irem, et al.
Publicado: (2020)

Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein
por: Zhang, Ying, et al.
Publicado: (2022)

Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
por: Koh, Kyung-Nam, et al.
Publicado: (2017)

Effective Irinotecan (CPT‐11)‐containing Liposomes: Intraliposomal Conversion to the Active Metabolite SN‐38
por: Sadzuka, Yasuyuki, et al.
Publicado: (1999)

Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
por: Yoon, Jong Hyung, et al.
Publicado: (2009)

The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
por: Lee, Se Ryeon, et al.
Publicado: (2009)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia
por: Lee, Julia S., et al.
Publicado: (2023)

Propylamine–borane
por: Gainsford, Graeme J., et al.
Publicado: (2009)

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
por: Corsini, C, et al.
Publicado: (2000)

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients
por: Capria, Saveria, et al.
Publicado: (2012)

Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
por: Zhao, Defeng, et al.
Publicado: (2014)

Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring
por: Maliszewska, Olga, et al.
Publicado: (2020)

Optimized Loading of Idarubicin in CalliSpheres(®) Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
por: Lu, Enhao, et al.
Publicado: (2021)

Relative humidity and qualities of hygroscopic medications stored in different one-dose packaging papers
por: Matsuo, Taisuke, et al.
Publicado: (2020)

Effects of thickened drinks on the disintegration of various oral tablets
por: Matsuo, Taisuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3urkehunr2qohtb3rnjal9a478